Rockefeller Capital Management L.P.

Position in ROIV — Roivant Sciences Ltd.

CIK 1739439 NEW YORK, NY

Position in ROIV

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,924,223

+$421,305 QoQ

Shares Held

54,372

+0.2% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#199

of 494 holders

Holding Since

Jun 2022

8 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

Rockefeller Capital Management L.P. holds $307,135,851 across 241 Biotechnology names. ROIV ranks #22 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	149,476	$74,249,211
2	JAZZ	Jazz Pharmaceuticals plc	167,409	$40,340,545
3	ACAD	Acadia Pharmaceuticals Inc	1,015,420	$25,690,124
4	BMRN	Biomarin Pharmaceutical Inc	433,376	$24,797,774
5	PTCT	Ptc Therapeutics, Inc.	302,393	$24,666,195
6	MDGL	Madrigal Pharmaceuticals, Inc.	29,015	$15,579,603
7	REGN	Regeneron Pharmaceuticals, Inc.	21,563	$13,445,391
8	CORT	Corcept Therapeutics Inc	123,388	$10,728,585

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,924,223	54,372	+0.2%	Shares	Defined	2026-08-13
2026-03-31	$1,502,918	54,257	+1436.2%	Shares	Defined	2026-05-14
2025-12-31	$76,644	3,532	-7.7%	Shares	Defined	2026-03-17
2025-09-30	$57,887	3,826	-86.4%	Shares	Defined	2025-11-14
2024-03-31	$297,385	28,215	+840.5%	Shares	Defined	2024-05-14
2022-12-31	$23,970	3,000	0.0%	Shares	Defined	2023-03-06
2022-09-30	$9,660	3,000	0.0%	Shares	Defined	2022-11-02
2022-06-30	$12,210	3,000	—	Shares	Defined	2022-08-12
No filing history on record for this holder in this stock.